Impact Of Rising Chronic Diseases On Smart Drug Delivery Systems Market Driver: Leading Transformation in the Smart Drug Delivery Systems Market in 2025

What industry-specific factors are fueling the growth of the smart drug delivery systems market?
The growing occurrence of long-term health issues or chronic diseases is predicted to boost the expansion of the smart drug delivery systems market. These diseases often advance slowly, possess complex origins, and their incidence is rising due to factors such as aging populations, environmental effects, and unequal access to healthcare. Smart drug delivery systems provide an effective solution for chronic disease management by improving the efficacy of medication and promoting patient compliance. For example, the National Library of Medicine, a US-based medical library, projected in January 2023 that by 2050, the number of individuals suffering from at least one chronic illness will reach 142.66 million, marking a 99.5% increase from 71.522 million in 2020. As a result, the escalating occurrence of chronic diseases is fueling the growth of the smart drug delivery systems market.

Get Your Smart Drug Delivery Systems Market Report Here:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

What Is the projected market size and growth rate for the smart drug delivery systems market?
The market size for smart drug delivery systems has experienced a swift expansion in the past few years. Its growth is projected to escalate from $12.65 billion in 2024 to $15.17 billion in 2025, representing a compound annual growth rate (CAGR) of 19.9%. The upsurge during the historic period can be credited to factors such as heightened demand for drug delivery systems, improved patient compliance, increasing incidence of chronic diseases, the rise in personalized medicine, and the necessity for affordable healthcare solutions.

The market size of intelligent drug delivery systems is predicted to see a swift expansion in the coming years, projected to reach $31.01 billion in 2029 with a compound annual growth rate (CAGR) of 19.6%. This potential growth in the projection period can be credited to the rising prevalence of non-communicable diseases, heightened emphasis on precision medicine, emergence of theragnostic, escalating need for non-intrusive methods of drug delivery, and the growth in healthcare spending. Key trends during the forecast period involve technologies related to miniaturization and microfabrication, advancements in the field of material science, the inclusion of artificial intelligence (AI) and machine learning (ML), the progression of nano-scale drug delivery systems, and the integration of Internet of Things (IoT) and wearable technology.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

What new trends are reshaping the smart drug delivery systems market and its opportunities?
Leading firms in the intelligent drug delivery systems sector are turning their attention to the production of reusable drug delivery devices like Qfinity, aiming to create a significant shift in how medications are administered. Whereas disposable tools are utilized once and then discarded, Qfinity is a drug delivery device that can be used multiple times. As an example, Qfinity, a reusable drug delivery instrument formulated for self-administration of medications via subcutaneous injection, was introduced by Jabil Inc, a manufacturing services organization from the US, in May 2022. The tool is designed to manage upwards of 100 injections per item, can hold either 1 mL or 2.25 mL pre-loaded containers, and results in a 60% reduction in the carbon footprint per injection. Qfinity's autoinjector platform is adaptable, with a wide set of technical standards for drug volumes and viscosities. Furthermore, Qfinity+ is a connected variant that facilitates distanced supervision of patient care and adherence by incorporating sensors and electronics, thereby ensuring connectivity without impacting user-friendliness.

What major market segments define the scope and growth of the smart drug delivery systems market?
The smart drug delivery systems market covered in this report is segmented -

1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users

Subsegments:
1) By Connected Inhalers: Dry Powder Inhalers (DPIs), Metered Dose Inhalers (MDIs)
2) By Connected Autoinjectors: Single-Dose Autoinjectors, Multi-Dose Autoinjectors
3) By Connected Pen Injectors: Insulin Pen Injectors, Biologic Pen Injectors
4) By Connected Wearable Injectors: Insulin Wearable Injectors, Infusion Pump Wearable Injectors
5) By Add-On Sensors: Glucose Monitoring Sensors, Medication Adherence Sensors, Temperature Sensors
6) By Other Products: Smart Syringes, Smart Patches, Smart Implants

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=14796

North America was the largest region in the smart drug delivery systems market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Which key market leaders are driving the smart drug delivery systems industry growth?
Major companies operating in the smart drug delivery systems market are Pfizer Inc., Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc., Boston Scientific Corporation, Biogen Inc., Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc., Insulet Corporation, Owen Mumford Ltd., Sonceboz, H&T Presspart Manufacturing Ltd., E3D Elcam Drug Delivery Devices, CeQur Corporation

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=14796&type=smp

What Is Covered In The Smart Drug Delivery Systems Global Market Report?

•Market Size Forecast: Examine the smart drug delivery systems market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the smart drug delivery systems market for a structured understanding.
•Key Players Overview: Analyze major players in the smart drug delivery systems market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the smart drug delivery systems market.
•Segment Contributions: Evaluate how different segments drive overall growth in the smart drug delivery systems market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the smart drug delivery systems market.
•Industry Challenges: Identify potential risks and obstacles affecting the smart drug delivery systems market.
•Competitive Landscape: Review strategic developments in the smart drug delivery systems market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.